BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7577043)

  • 1. The role of interferon-alpha as a modulator of fluorouracil and leucovorin.
    Grem JL; van Groeningen CJ; Ismail AA; Johnston PG; Alexander HR; Allegra CJ
    Eur J Cancer; 1995; 31A(7-8):1316-20. PubMed ID: 7577043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
    Makower D; Wadler S
    Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
    Vermeulen PB; Dirix LY; Pelgrims G; Van Oosterom AT
    Cancer; 1995 Aug; 76(3):528-30. PubMed ID: 8625138
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations.
    Grem JL; Chu E; Boarman D; Balis FM; Murphy RF; McAtee N; Allegra CJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):36-44. PubMed ID: 1557656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomodulation of 5-fluorouracil by interferon].
    Aiba K
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1018-27. PubMed ID: 7611752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction of 5-fluorouracil and interferon alpha-2b with or without folinic acid.
    b1p6uller J; Czejka M
    Med Oncol; 1995 Mar; 12(1):47-53. PubMed ID: 8542247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of leucovorin dosing and administration schedule.
    Jolivet J
    Eur J Cancer; 1995; 31A(7-8):1311-5. PubMed ID: 7577042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
    Wolmark N; Bryant J; Smith R; Grem J; Allegra C; Hyams D; Atkins J; Dimitrov N; Oishi R; Prager D; Fehrenbacher L; Romond E; Colangelo L; Fisher B
    J Natl Cancer Inst; 1998 Dec; 90(23):1810-6. PubMed ID: 9839521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a.
    Yee LK; Allegra CJ; Steinberg SM; Grem JL
    J Natl Cancer Inst; 1992 Dec; 84(23):1820-5. PubMed ID: 1433371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
    Nichols PH; Ward U; Ramsden CW; Primrose JN
    Br J Cancer; 1994 Nov; 70(5):946-9. PubMed ID: 7947102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.
    Punt CJ; Burghouts JT; Croles JJ; van Liessum PA; de Mulder PH; Kamm Y
    Cancer; 1993 Oct; 72(7):2107-11. PubMed ID: 8374869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
    Oncology; 2000 Apr; 58(3):227-36. PubMed ID: 10765125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin.
    Grem JL
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-8-S18-18. PubMed ID: 9420016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase.
    Morita T; Tokue A
    Cancer Chemother Pharmacol; 1999; 44(2):91-6. PubMed ID: 10412941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
    Shapiro JD; Harold N; Takimoto C; Hamilton JM; Vaughn D; Chen A; Steinberg SM; Liewehr D; Allegra C; Monahan B; Lash A; Grollman F; Flemming D; Behan K; Johnston PG; Haller D; Quinn M; Morrison G; Grem JL
    Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
    Seymour MT; Slevin ML; Kerr DJ; Cunningham D; James RD; Ledermann JA; Perren TJ; McAdam WA; Harper PG; Neoptolemos JP; Nicholson M; Duffy AM; Stephens RJ; Stenning SP; Taylor I
    J Clin Oncol; 1996 Aug; 14(8):2280-8. PubMed ID: 8708718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.